Since multiple sclerosis is a chronic disease with no cure or control, the role of a caregiver or care partner is very important, said June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers.
Since multiple sclerosis is a chronic disease with no cure or control, the role of a caregiver or care partner is very important, said June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers.
Transcript
How important of a role do caregivers play within the care team for patients with multiple sclerosis (MS)?
Caregivers, it depends on how you describe the word caregivers. Are you talking about family members? Certainly, caregivers or care partners are vital in any chronic illness. The care partner, the care partner support is vital to help the patient through the hump of being diagnosed, then the hump of having a relapse or getting worse or starting a new medication.
But also, you could define a caregiver as somebody professional, such as a nurse, a physician, a rehab specialist, mental health expert. So, the caregiving model in MS is extremely important, because it’s a disease that lasts a lifetime and trying to tackle this by yourself is a lonely job. So, everyone needs someone who understands what you’ve been through.
The other caregiver or care partner could be someone else with MS. The role of a support group can’t be underestimated. To have someone that understands your feelings, that feeling of isolation or the feeling of uncertainty. So, sometimes the caregiver or care partner is someone else who is undergoing the diagnostic experience or dealing with the ongoing problems of MS.
I think until we start seeing more of a cure or a control of the disease, that whole caregiving model is a very important model for us to deal with.
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Distinguishing Biomarkers Identified in MS Outcomes
March 19th 2024Results from this cohort study found that levels of glial fibrillary acid protein, cerebral spinal fluid, and neurofilament heavy chain are distinguishable biomarkers that are associated with disease outcomes in multiple sclerosis (MS).
Read More
FDA Issues CRL for Glatiramer Acetate Depot for Relapsing Forms of MS
March 11th 2024The FDA has declined to approve glatiramer acetate (GA) depot in the treatment of relapsing types of multiple sclerosis (MS), issuing a complete response letter (CRL) for the long-acting, injectable form of GA.
Read More
Getting to Know Dr Fabiola Molina, Hospitalist
February 26th 2024Fabiola Molina, MD, MHS, is a practicing hospitalist and assistant professor of medicine at Yale School of Medicine and Yale New Haven Hospital. An immigrant from Mexico, her experiences straddling 2 worlds, while attempting to navigate with her family the complicated safety-net system for health care in Texas, were key influences to her ardent focus on health equity.
Read More